pH-Responsive Nanoparticles for Oral Insulin Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering large protein molecules, such as insulin, via oral administration face challenges including survival in the gastrointestinal tract's acidic environment, efficient transport across the intestinal epithelium, and rapid release before excretion, due to sensitivity to pH fluctuations and enzyme activity.
Innovation Solution
Development of pH-responsive nanoparticles composed of a blend of pH-sensitive and pH-insensitive polymers, such as Eudragit and PLGA-PEG, which remain intact in acidic conditions and rapidly release the payload at neutral pH, facilitating oral delivery through the FcRn pathway.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If nanoparticles are made small enough to cross intestinal epithelium efficiently, then transcytosis efficiency is improved, but drug loading capacity deteriorates
Solution Approach 1:
The patent employs a core-shell nanoparticle structure where the payload molecule is encapsulated within the core, and the pH-responsive polymer forms a protective shell around it. This nested architecture allows the nanoparticle to maintain a small size for efficient transcytosis while providing sufficient internal volume for adequate drug loading capacity.
2Stability of the object's composition
If nanoparticles remain stable in acidic gastrointestinal environment, then survival through GI tract is improved, but rapid release in bloodstream deteriorates
Solution Approach 1:
The patent utilizes a pH-responsive polymer that changes its physical or chemical properties in response to pH variations. The polymer remains in a stable, intact state at acidic pH (protecting the payload during GI tract transit) and undergoes a conformational change or degradation at neutral pH (triggering rapid payload release in the bloodstream), thus resolving the contradiction between stability and release speed.
3Reliability
If frequent intravenous or subcutaneous injections are used to deliver drugs, then drug delivery effectiveness is improved, but patient compliance and convenience deteriorate
Solution Approach 1:
The patent develops a multi-functional nanoparticle system that combines oral delivery capability, pH-responsive payload release, and potential targeting functionality into a single platform. This universal system can replace multiple administration routes (oral, intravenous, subcutaneous) with a single oral dosage form, thereby improving patient compliance while maintaining delivery effectiveness through its ability to navigate the GI tract and release payload in response to pH changes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles achieve efficient oral delivery of insulin by maintaining stability in the gastrointestinal tract and triggering rapid release in the bloodstream, enhancing bioavailability and reducing excretion, with optimized size and loading for effective transcytosis.
Implementation Method 1
the pH-responsive polymer is blended with the pH-insensitive polymer forming a mixture of the polymers... the aqueous solubility of which varies from being substantially insoluble to being substantially soluble with changes in pH
Data Source
AI summary
Provided is a nanoparticle comprising a pH-responsive polymer, a pH-insensitive polymer and a payload molecule. The nanoparticle can act as a system for delivery of the payload that releases the payload in a pH sensitive manner.